Wall Street Analysts Predict a 282.65% Upside in Rapt Therapeutics (RAPT): Here's What You Should Know

Shares of Rapt Therapeutics (RAPT) have gained 1.7% over the past four weeks to close the last trading session at $7.84, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $30 indicates a potential upside of 282.7%.The average comprises four short-term price targets ranging from a low of $8.00 to a high of $48.00, with a standard deviation of $21.04. While the lowest estimate indic ...